Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

25 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Gadofosveset Trisodium Injection for Intravenous Use Articles

Intercell's Ixiaro JE vacc recommended for EU approval

8 April 2009

Epix stock triples on Vasovist approval

12 January 2009

EPIX regains Vasovist rights from Bayer

15 September 2008

South Korea approves EPIX' Vasovist

21 July 2008

EPIX discontinues MDD drug on poor efficacy

31 March 2008

Bayer/Schering AG present R&D pipeline, highlighting Nexavar, Campath and Yaz

6 November 2006

Stock Commentary - Europe - week to Nov 28

5 December 2005

FDA accepts EPIX' Vasovist submission

11 July 2005

Positive CHMP opinion for Schering AG's Vasovist

4 July 2005

Schering AG commits to operating margin of 16% this year and 18% in 2006

4 July 2005

Showing 1-10 of 10 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Proposal to list Roche's Neulastim and Actemra in New Zealand
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Proposal to list Roche's Neulastim and Actemra in New Zealand
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS